Page last updated: 2024-09-04

rhodioloside and Non-alcoholic Fatty Liver Disease

rhodioloside has been researched along with Non-alcoholic Fatty Liver Disease in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's4 (57.14)2.80

Authors

AuthorsStudies
Dun, Y; Li, D; Li, H; Liu, J; Liu, S; Qiu, L; Ripley-Gonzalez, JW; You, B; Zhang, J1
Liang, Y; Liu, X; Lu, L; Qu, B; Zhang, C; Zheng, K1
Hu, Y; Li, H; Tian, H; Xi, Y; Xin, X1
Hu, M; Huang, X; Qi, Z; Shi, H; Wang, X; Wu, Y; Xu, H; Zhang, D; Zhang, Y1
Bian, F; Chen, L; Jin, S; Li, W; Wang, Q; Wu, D; Xing, S; Yang, X; Zheng, T1
Li, HS1
Dai, N; Guan, LL; Wang, HF; Yang, ZR; Zuo, TC1

Reviews

1 review(s) available for rhodioloside and Non-alcoholic Fatty Liver Disease

ArticleYear
Salidroside in the Treatment of NAFLD/NASH.
    Chemistry & biodiversity, 2022, Volume: 19, Issue:12

    Topics: Fibrosis; Glucosides; Humans; Liver; Liver Cirrhosis; Non-alcoholic Fatty Liver Disease

2022

Other Studies

6 other study(ies) available for rhodioloside and Non-alcoholic Fatty Liver Disease

ArticleYear
Rhodiola activates macrophage migration inhibitory factor to alleviate non-alcoholic fatty liver disease.
    Life sciences, 2022, Nov-01, Volume: 308

    Topics: Animals; Blood Glucose; Diet, High-Fat; Glucosides; Insulin; Lipid Metabolism; Liver; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palmitates; Phenols; Plant Extracts; Rhodiola; RNA, Small Interfering; Saline Solution; Triglycerides

2022
Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 124

    Topics: Animals; Bile Acids and Salts; Diet, High-Fat; Disease Models, Animal; Gastrointestinal Microbiome; Glucosides; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Phenols; Receptors, Cytoplasmic and Nuclear; Triglycerides

2020
Salidroside Activates the AMP-Activated Protein Kinase Pathway to Suppress Nonalcoholic Steatohepatitis in Mice.
    Hepatology (Baltimore, Md.), 2021, Volume: 74, Issue:6

    Topics: AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diet, High-Fat; Disease Models, Animal; Glucosides; Hepatocytes; Humans; Liver; Male; Mice; Non-alcoholic Fatty Liver Disease; Phenols; Primary Cell Culture; Signal Transduction

2021
Salidroside Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease via AMPK-Dependent TXNIP/NLRP3 Pathway.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Animals; Diet, High-Fat; Glucosides; Male; Mice; Non-alcoholic Fatty Liver Disease; Phenols; Rhodiola

2018
Salidroside and Curcumin Formula Prevents Liver Injury in Nonalcoholic Fatty Liver Disease in Rats.
    Annals of hepatology, 2018, Aug-24, Volume: 17, Issue:5

    Topics: AMP-Activated Protein Kinases; Animals; Biomarkers; Blood Glucose; Curcumin; Diet, High-Fat; Disease Models, Animal; Drug Combinations; Glucosides; Insulin; Insulin Resistance; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Non-alcoholic Fatty Liver Disease; Phenols; Rats, Sprague-Dawley; Signal Transduction

2018
Salidroside alleviates oxidative stress in the liver with non- alcoholic steatohepatitis in rats.
    BMC pharmacology & toxicology, 2016, Apr-14, Volume: 17

    Topics: Administration, Oral; Animals; Antioxidants; Cytochrome P-450 CYP2E1; Diet, High-Fat; Dose-Response Relationship, Drug; Enzyme Repression; Glucosides; Lipid Droplets; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Membrane Glycoproteins; NADPH Oxidase 2; NADPH Oxidases; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Oxidoreductases; Phenols; Random Allocation; Rats, Sprague-Dawley; Up-Regulation

2016